Bellerophon Therapeutics, Inc
.
|
Delaware
|
001-36845
|
47-3116175
|
(State or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
184 Liberty Corner Road, Suite 302
Warren, New Jersey
|
07059
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
(Former Name or Former Address, if Changed Since Last Report)
|
|
x
|
Emerging growth company
|
|
x
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
BLPH
|
The Nasdaq Global Market
|
|
|
|
|
Name
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
Mary Ann Cloyd
|
45,539,004
|
1,707,604
|
11,164,290
|
Crispin Teufel
|
47,040,264
|
206,344
|
11,164,290
|
|
|
|
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
57,179,871
|
1,021,329
|
209,698
|
—
|
|
|
|
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
43,828,312
|
3,341,568
|
76,728
|
11,164,290
|
|
|
|
|
|
|
|
|
|
|
|
BELLEROPHON THERAPEUTICS, INC.
|
||
|
|
|
|
|||
Date: May 14, 2019
|
|
|
|
By:
|
|
/s/ Assaf Korner
|
|
|
|
|
|
|
Assaf Korner
Chief Financial Officer
|